poweredbyCULTURE
Win $500. Find the company you work for and post about an employee experience, add images. Post by 7/1/2022 to be eligible. WRITE A CULTURE POST
Posted By Cystic Fibrosis Foundation on 12/26/2019

Adding Tomorrows - Cystic Fibrosis Foundation


The FDA recently approved Kalydeco, the first drug to address the underlying cause of cystic fibrosis for a small segment of the CF population. Meet two children who are still in need of a lifesaving treatment for CF.

Company Videos Search

We Love Staying Connected